Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review.
Rezapour Aziz, Alidoost Saeide, Asgharzadeh Asra, +8 more·Medical journal of the Islamic Republic of Iran
In recent years, increased longevity, poor dietary habits, and the rising prevalence of metabolic syndrome and hypertension have increased the prevalence of gout. Gout significantly increases direct and indirect costs and reduces the quality of life. Allopurinol and febuxostat are the most commonly used drugs for reduc…